CAMP
CAMP4 Therapeutics Corporation
There isn't enough reported data to score CAMP yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
CAMP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Under pressure | |
| Weak |
CAMP's profitability, cash flow and balance sheet are currently under pressure. There isn't enough data to rate its revenue.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAMP PE Valuation
CAMP has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
CAMP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect CAMP's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
CAMP Earnings Per Share
CAMP lost $2.13 per share over the past year, a bigger loss than the year before.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over CAMP in the latest year-over-year earnings comparison.
CAMP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.9M | +139% |
| Q2 2026 | $1.8M | +19% |
| Q1 2026 | $1.3M | +51% |
| Q3 2023 | $350K | -100% |
| Q2 2023 | $70.9M | +9.5% |
| Q1 2023 | $78.5M | +15% |
| Q4 2022 | $78.9M | +15% |
| Q3 2022 | $72.8M | -7.8% |
CAMP's revenue is recovering but still below its 2020 peak: $2M last quarter, up 139% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -739% | +978 points |
| Q2 2026 | -752% | +118 points |
| Q1 2026 | -1010% | +517 points |
| Q4 2025 | -3671% | N/A |
| Q3 2025 | -1717% | N/A |
| Q2 2025 | -870% | N/A |
| Q1 2025 | -1527% | N/A |
| Q3 2023 | -3525% | -3518 points |
CAMP's operating margin was −739% last quarter, up 978 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over CAMP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over CAMP on profitability, with a higher operating margin.
CAMP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.9M | +$2.3M |
| Q2 2026 | -$12.8M | -$2.5M |
| Q1 2026 | -$11M | +$3.6M |
| Q4 2025 | $6.3M | +$17.8M |
| Q2 2025 | -$10.3M | +$3.3M |
| Q1 2025 | -$14.6M | -$3.4M |
| Q4 2024 | -$11.6M | +$475K |
| Q2 2024 | -$13.6M | -$10.5M |
CAMP has burned cash in most quarters: −$26M over the past year, against −$48M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over CAMP on cash generation, producing positive trailing cash flow while its opponent burns cash.
CAMP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2021 | 25.3x | High |
| Q2 2021 | 14.1x | High |
| Q1 2021 | 8.2x | High |
| Q4 2020 | 15.9x | High |
| Q3 2020 | 16.1x | High |
| Q2 2020 | 9.9x | High |
| Q1 2020 | 13.2x | High |
CAMP's net debt is more than 20 years of its operating earnings (EBITDA), up from 16 years a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
CAMP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.5 | Neutral |
| Stochastic | 35.4 | Neutral |
CAMP's weekly RSI is 51 (neutral) and its Stochastic is 35 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
CAMP PE vs Healthcare Sector
CAMP has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
CAMP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.78 | 8.2% above |
| 20 week MA | $4.03 | 1.5% above |
| 50 week MA | $4.39 | 6.8% below |
| 100 week MA | $3.75 | 9.1% above |
LLY has stronger trend alignment. CAMP is above 3 of 4 weekly averages versus LLY above 5 of 5.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY is in an uptrend: it's above all five of its weekly moving averages, and 79% above its 200-week average.
CAMP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $10.7 | $5.43 | -49% |
| 2025 | $5.43 | $5.96 | +9.8% |
| 2026 YTD | $5.96 | $4.09 | -31% |
CAMP has finished lower in one of the last two years. It's down 31% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over CAMP on returns for 2026, with the stronger performance.